Profile
TOVX VRTX ALNY REGN ARGX SGEN
Company Name Theriva Biologics, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $8.06M $100.41B $61.64B $58.82B $48.74B $43.15B
Employees 0.02K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Steven A. Shallcross CPA Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
TOVX VRTX ALNY REGN ARGX SGEN
Quant Rating Score 3 3 1 4 3 3
Quant Rating Neutral Neutral Strong Sell Buy Neutral Neutral
Trading
TOVX VRTX ALNY REGN ARGX SGEN
Last Close $0.84 $407.9 $470.27 $576.42 $815.61 $228.74
High 52 $2.16 $516.74 $482.13 $998.23 $815.61 $228.74
Low 52 $0.37 $366.54 $224.58 $482.92 $532.27 $228.74
Price vs. 52 Week High -61.11 % -21.06 % -2.46 % -42.26 % 0 % 0 %
Price vs. 52 Week Low 127.03 % 11.28 % 109.4 % 19.36 % 53.23 % 0 %
Total Return
TOVX VRTX ALNY REGN ARGX SGEN
1 Month Return 101.44 % 4.23 % 2.01 % 0.26 % 8.41 % 0 %
3 Month Return 80.26 % -13.13 % 45.68 % 5.31 % 41.3 % 0 %
6 Month Return -36.37 % -16.05 % 104.02 % 4.94 % 38.81 % 0 %
9 Month Return -41.26 % -2.17 % 88.74 % -16.85 % 23.61 % 0 %
YTD Return -52 % 1.29 % 99.85 % -19.08 % 32.62 % 0 %
1 Year Return -42.07 % -18.21 % 58.47 % -42.26 % 49.97 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TOVX VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -1129.5 % 11.09 % -0.43 % 4.37 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
TOVX VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM -5.84 % 86.11 % 83.64 % 81.98 % 65.82 % 79.1 %
Return on Assets TTM -82.49 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -169.32 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -89.02 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 141.66 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -13547.4 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -1443.45 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.27 3.59 3.93 3.54 0.9 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.26 0.96
Fixed Asset Turnover TTM 11.54 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 0.43 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -2.68 14.98 -0.12 45.13 5.67 -2.46
Free Cash Flow Per Share TTM -2.68 13.63 -0.4 36.58 5.58 -2.88
Cash Per Share TTM 179.48 % 2486.48 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -11735.06 % 33.68 % -0.63 % 33.37 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.09 % 90.99 % 335.21 % 81.05 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM -1443.45 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM -0.45 28.69 -1183.43 15.3 123.13 -81.26
Price To Operating Cash Flows Ratio TTM -0.31 26.14 -3924.5 12.51 140.63 -93.1
Price Cash Flow Ratio TTM -0.31 26.14 -3924.5 12.51 140.63 -93.1
Income Statement (TTM)
TOVX VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $-0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 0% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.03B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.03B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -19.03 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
TOVX VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.02B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.02B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.04B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
TOVX VRTX ALNY REGN ARGX SGEN
Net Income $-0.03B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 36.92
AARD Aardvark Therapeutics, Inc. Common Stock 13.29
ABCL AbCellera Biologics Inc. 5.835
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.4383
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.13
ABPWW 0.0325
ABSI Absci Corporation 4.8682
ABUS Arbutus Biopharma Corporation 4.51
ABVC ABVC BioPharma, Inc. 2.9
ABVX Abivax SA American Depositary Shares 92.52
ACAD ACADIA Pharmaceuticals Inc. 20.575
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.0235
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.07
ACIU AC Immune SA 2.99
ETFs With Exposure to TOVX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 325.65
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 144.545
VXF Vanguard Extended Market Index Fund 0.00001 209.1
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00001 161.24
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000145293 16.19
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00001 161.25
VEMPX Vanguard Extended Market Index InstlPlus 0.00001 397.91
Unlock